Möchten Sie immer auf dem neuesten Stand bleiben?

SKYX Signs a Licensing Agreement for Its Advanced Technologies with U.S., Canada, and Global Leading Lighting Company Eurofase

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002 to Jupiter Neurosciences in a Transaction Valued at Over $100 Million USD

BRUXELLES, 20 mai 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, ci-après « SERB », et Hansa Biopharma AB, ci-après « Hansa » (Nasdaq Stockholm : HNSA) annoncent la conclusion d’un accord portant...

BRÜSSEL, May 20, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals („SERB“) und Hansa Biopharma AB („Hansa“) (Nasdaq Stockholm: HNSA) gaben heute bekannt, dass sie eine Vereinbarung getroffen...

WILMINGTON, Del., May 19, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company, today announced that the company has...

SERB Pharmaceuticals to acquire development and commercialisation rights to Idefirix® (imlifidase) in Europe and MENA from Hansa Biopharma for €115 million

SANTA MONICA, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK) a leading designer, manufacturer and marketer of toys and consumer products, has renewed and extended its...

Terra Innovatum Global N.V. (NASDAQ: NKLR) Secures Water-Independent Cooling Solution for SOLO™ Reactor Through Supply Agreement with SPG Dry Cooling

Context announces buyout of CT-202 future milestones and royalties in exchange for a fully paid-up, non-terminable license Phase 1 initiation for CT-202 trial expected in third quarter of 2026 ...

Licensing Expo returns to Las Vegas May 19-21 with an exceptional lineup of more than 400 brands and extensive education, convening the entire industry